American Gene Technologies®
In The News
ShareTreck: Raj Natarajan Interviews American Gene™ CEO, Jeff Galvin
Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ in this compelling interview to learn how gene therapy works, and what it means for people with deadly diseases, as well as how it will impact the…
Read More
From Lab to Launch Podcast: Testing a Gene Therapy to Potentially Cure HIV & Fundamentally Change Healthcare with Jeff Galvin
Have a listen. From Lab to Launch by Qualio Jeff is the CEO and founder of American Gene Technologies®. He earned his BA degree in Economics from Harvard and has more than 30 years of business and entrepreneurial experience including founder or executive positions at…
Read More
Queerty: Gay men are the “canary in the coal mine” of future pandemics, warns doc seeking HIV cure
Original post on queerty.com By David Hudson The trial of a potential HIV cure is underway. The scientists involved hope for initial results toward the end of the year. One of them also has stark warnings about the threat to humanity of future pandemics. He…
Read More
Unboxing Biotech Analyst Report: The Foundation Behind a Potential HIV Cure
Download the Report The exact origins of Human Immunodeficiency Virus (HIV) are not precisely known, but researchers theorize that the virus may have originated in chimpanzees,1and then crossed to humans via blood borne pathway. It is not radically different from many of the other retroviruses…
Read More
The Baltimore Sun: Maryland Might Lose Out on a New $1 Billion Federal Medical Research Accelerator
Original post on baltimoresun.com By Giacomo Bologna and Meredith Cohn Baltimore Sun At his State of the Union speech in March, President Joe Biden urged Congress to fund a new federal agency that would “supercharge” breakthrough medical research and “end cancer as we know it.” Congress…
Read More
CityBiz: American Gene Technologies® Appoints Dr. Jeff Boyle as Chief Science Officer
Original post on citybiz.co American Gene Technologies, a clinical-stage biotechnology company, has appointed Jeff Boyle, PhD as chief science officer. Dr. Boyle comes to the post with deep biotechnology expertise which will help further accelerate the company’s FDA-approved HIV gene therapy clinical trial that expects to see…
Read More
ABC7 News: Progress in HIV cure: AGT™ hopes to have a ‘functionally cured patient by next summer’
Original post on WJLA.com We have an update in what developers hope will be an HIV cure, a story we’ve been following for more than a year now. A Maryland-based company says its early data in three patients shows their altered cells are not…
Read More
ABC7 News: ‘I see amazing momentum.’ Efforts to find HIV cure are speeding up in Maryland
Original post on WJLA.com The efforts to find a functional cure for HIV are speeding up for one Maryland company after the Data Safety and Monitoring Board found no serious, adverse events with the third patient, as was the case for the previous two, American…
Read More
ABC7 News: American Gene Technologies® says clinical trial shows increases in immunity against HIV
Original post on ABC7 News ROCKVILLE, Md. (7News) – There’s more good news in the fight to cure HIV. American Gene Technologies says its clinical trial has resulted in more patients with substantial increases in virus-specific T-cells with immunity against HIV. Progress in…
Read More
Authority Magazine: Gene Therapy: “Jeff Galvin’s Big Idea That Might Change The World”
Original Post on medium.com Don’t mistake “wants” for “needs” in your life. We hardly need anything to survive, and if we don’t get caught up on the materialistic world that media, corporations, and politicians sell us in order to perpetuate their agendas, it leaves us…
Read MoreSubscribe to News Releases and News Updates
Subscribe to our news release and published article updates to be notified when we release new content!
Follow AGT on Social Media
AGT on Facebook
